drugset / Trial / NCT00000342

Risperidone for the Treatment of Cocaine Dependence - 7

NCT00000342

Parallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate clinical safety and pharmacological efficacy in the treatment of cocaine dependence, to evaluate impact of treatment on craving, and to correlate evidence of baseline neurotoxic damage of cocaine with treatment outcome and clinical side-effects.

Timeline

Start
1996-07
Primary completion
1997-08
Completion
1997-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Risperidone Other / unclassified

Indications